Prosecution Insights
Last updated: April 19, 2026

Examiner: KAMM, JUDITH MARIE

Tech Center 1600 • Art Units: 1611

This examiner grants 40% of resolved cases

Performance Statistics

40.4%
Allow Rate
-19.6% vs TC avg
95
Total Applications
+59.0%
Interview Lift
1422
Avg Prosecution Days
Based on 52 resolved cases, 2023–2026

Rejection Statute Breakdown

2.8%
§101 Eligibility
7.7%
§102 Novelty
42.1%
§103 Obviousness
27.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18013508 GSK3 INHIBITOR-LOADED NANO FORMULATIONS AS A CANCER IMMUNOTHERAPEUTIC Final Rejection The Regents of the University of California
19276575 LYOPHILIZED ORALLY DISINTEGRATING TABLET FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS Non-Final OA Mind Medicine, Inc.
17972972 PLASTICIZERS TO IMPROVE RELEASE PERFORMANCE OF AMORPHOUS SOLID DISPERSIONS Non-Final OA Purdue Research Foundation
18050593 COSMETIC COMPOSITIONS COMPRISING HIGH AMOUNTS OF RETINOL Final Rejection L'OREAL
18041618 NANOPARTICULATE SYSTEM FOR TREATING ORAL CANCER Non-Final OA THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
18039554 COMPOSITIONS COMPRISING MESOSULFURON-METHYL AND TEHP Non-Final OA BAYER AKTIENGESELLSCHAFT
18018205 TRANS-CROCETIN COMPOSITIONS AND TREATMENT REGIMENS Non-Final OA L.E.A.F. HOLDINGS GROUP LLC
18681625 METHOD FOR THE PASSIVATION OF SURGICAL IMPLANTS COMPRISING TITANIUM, AND SURGICAL IMPLANT OBTAINED Non-Final OA IQC2010 S.L.
18423812 AMORPHOUS NANO-MOLECULAR AGGREGATE COMPOSED OF ORGANIC MATERIAL, INORGANIC MATERIAL, OR SALT THEREOF, AND METHOD FOR PREPARING SAME Non-Final OA SCAI THERAPEUTICS CO., LTD.
17604227 Compositions and Methods of Manufacturing Star Polymers for Ligand Display and/or Drug Delivery Final Rejection The United States of America, as represented by the Secretary, Department of Health and Human Servic
17294677 OPACIFIER CONCENTRATE AND ITS USE TO MODIFY THE APPEARANCE AND/OR INCREASE OPACITY AND/OR WHITENESS OF AN AQUEOUS COMPOSITION Non-Final OA SPECIALTY OPERATIONS FRANCE
17633684 METHODS FOR PREVENTING AN IMMUNOGLOBULIN E-RELATED DISEASE Non-Final OA MY-OR DIAGNOSTICS LTD.
18084069 TESTIS-TARGETED LYCOPENE (LYC)/ZIF-90 NANOCOMPOSITE AND PREPARATION METHOD AND USE THEREOF Non-Final OA NORTHEAST AGRICULTURAL UNIVERSITY
17909696 COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR BACTERIAL INFECTIONS Final Rejection Endolytix Technology, Inc.
17625825 BIOPOLYMER-BASED MENISCUS IMPLANT Non-Final OA Shu-Tung and Alice Li Foundation Inc.
17426986 METHOD FOR OBTAINING AN EXTRACT OF PATCHOULI LEAVES AND COSMETIC USES THEREOF Non-Final OA JAFER ENTERPRISES R&D, S.L.U
16883625 SKIN PERMEATION ENHANCING COMPOSITION Final Rejection Professional Compounding Centers of America, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month